Jonathan C. Fox, See Remarks at Eidos Therapeutics, Inc. (EIDX), sold 11,000 shares at $58.90 ($589K) on 2019-12-04, disclosed to the SEC on 2019-12-05.
Open-market sale of $589k EIDX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,000 | $0 | 0.0% |
| 2 | $58.90 | 10,000 | $589K | 100.0% |
| Total | $53.55 avg | 11,000 | $589K | 100% |
| Filing → |
| EIDX | SELL | 2020-09-18 | $579K | — | Filing → |
| EIDX | SELL | 2020-09-16 | $369K | — | Filing → |
| EIDX | SELL | 2020-07-09 | $250K | — | Filing → |